Fulgent Genetics, Inc. (FLGT) Misses Q3 EPS by 7c ; Offers Guidance

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of ($0.39), $0.07 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $85 million versus the consensus estimate of $64.42 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2023 EPS of ~($0.95), versus the consensus of ($0.95). Fulgent Genetics, Inc. sees FY2023 revenue of ~$260 million, versus the consensus of $265.2 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
• American Outdoor Brands (AOUT) Tops Q4 EPS by 14c